SRTS · Insider Trading
Sensus Healthcare, Inc
Every open-market purchase and sale reported by SRTS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Eric Sachetta | Director | Buy | +64,841 | +$225.62K |
| 2026-08-28 | Eric Sachetta | Director | Buy | +20,633 | +$66.68K |
| 2026-08-25 | Eric Sachetta | Director | Buy | +34,697 | +$112.90K |
| 2026-08-24 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | +20,000 | +$60.49K |
| 2026-08-24 | Eric Sachetta | Director | Buy | +31,000 | +$97.85K |
| 2026-05-12 | Eric Sachetta | Director | Buy | +1,500 | +$5.00K |
| 2026-04-23 | Eric Sachetta | Director | — | — | — |
| 2026-04-22 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | −3,935 | −$41.36K |
| 2026-04-22 | Magdalena Martinez | CHIEF OPERATING OFFICER | F | −741 | −$1.97K |
| 2026-02-26 | Eric Sachetta | Director | Buy | +2,000 | +$7.62K |
| 2025-12-16 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | — | — | — |
| 2025-12-16 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | A | +40,000 | — |
| 2025-11-21 | Eric Sachetta | Director | Buy | +7,000 | +$27.51K |
| 2025-11-20 | Eric Sachetta | Director | Buy | +2,500 | +$11.25K |
| 2025-11-19 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | +25,000 | +$100.75K |
| 2025-11-19 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +1,000 | +$3.80K |
| 2025-11-18 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +2,000 | +$8.55K |
| 2025-11-13 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +2,000 | +$8.52K |
| 2025-11-12 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +1,000 | +$4.26K |
| 2025-08-14 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +1,000 | +$3.37K |
| 2025-02-10 | Javier Rampolla | CHIEF FINANCIAL OFFICER | Buy | +501 | +$2.98K |
| 2025-02-10 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +1,000 | +$5.95K |
| 2024-12-19 | Megan Cornish | Director | A | +20,000 | — |
| 2024-12-19 | Anthony Benedict Petrelli | Director | A | +20,000 | — |
| 2024-12-19 | William H McCall | Director | A | +20,000 | — |
| 2024-12-19 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | A | +40,000 | — |
| 2024-07-23 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | −3,935 | −$23.61K |
| 2024-07-23 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | F | −3,935 | −$23.61K |
| 2024-07-17 | William H McCall | Director | Sell | −10,000 | −$75.40K |
| 2024-07-17 | William H McCall | Director | A | +10,000 | — |
| 2024-07-17 | William H McCall | Director | J | −325,723 | — |
| 2024-05-24 | John Heinrich | Director | Sell | −20,000 | −$123.42K |
| 2024-01-16 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | A | +20,000 | — |
| 2023-12-20 | Magdalena Martinez | CHIEF OPERATING OFFICER | F | −741 | −$1.97K |
| 2023-09-18 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | +10,000 | +$28.77K |
| 2023-08-28 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +1,000 | +$2.99K |
| 2023-08-08 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +1,000 | +$3.78K |
| 2023-08-08 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | +10,000 | +$38.57K |
| 2023-07-31 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | −3,935 | −$11.92K |
| 2023-05-31 | John Heinrich | Director | Buy | +10,000 | +$28.60K |
| 2023-05-11 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | +25,000 | +$74.79K |
| 2023-05-10 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | +1,000 | +$3.00K |
| 2023-05-10 | Samuel O'Rear | Director | Buy | +20,000 | +$59.85K |
| 2023-02-03 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | −742 | −$6.56K |
| 2023-02-01 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | MIXED | +6,255 | −$33.56K |
| 2022-09-15 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | MIXED | — | −$42.88K |
| 2022-09-07 | Joseph C Sardano | Chief Executive Officer | Sell | −41,588 | −$521.26K |
| 2022-08-11 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Sell | −158,412 | −$2.24M |
| 2022-08-10 | Samuel O'Rear | Director | Sell | −50,000 | −$710.20K |
| 2022-07-25 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | −3,935 | −$41.36K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Joseph C Sardano | CHIEF EXECUTIVE OFFICER | 1,220,293 | $3.60M |
| Eric Sachetta | Director | 269,573 | $795.24K |
| Michael Sardano | PRESIDENT AND GENERAL COUNSEL | 159,839 | $471.53K |
| Anthony Benedict Petrelli | Director | 66,466 | $196.07K |
| Javier Rampolla | CHIEF FINANCIAL OFFICER | 48,114 | $141.94K |
| Megan Cornish | Director | 32,000 | $94.40K |
| William H McCall | Director | 30,000 | $88.50K |
| Magdalena Martinez | CHIEF OPERATING OFFICER | 12,013 | $35.44K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SRTS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.